SAFER, MORE EFFECTIVE REDUCES AGITATION HELPS PAIN AND WEIGHT GAIN MAY PROTECT THE BRAIN BETTER QUALITY OF LIFE FOR PATIENTS … More
A clinical trial to test the effects of THC on pain is underway at Yale University.
The study is one of 26 at Yale that are specific to cannabinoids.
Spanish researchers, in collaboration with Tilray, are testing a mixture of THC, CBD and chemo drug TMZ in a clinical trial involving newly diagnosed brain-cancer patients.
Aurora’s CanniMed cannabis-oil products to be used in a clinical trial for Parkinson’s disease.
The study will determine the safety and tolerability of three different formulations of the cannabis oil for pain in Parkinson’s patients.
New York University School of Medicine will conduct the first-ever study to test the hypothesis that oral CBD will reduce alcohol consumption in individuals suffering both PTSD and Alcohol Use Disorder.
A cannabis-derived drug that could reduce opioid fentanyl use for breakthrough cancer pain is one step closer thanks to Health Canada approval that will allow a clinical trial to begin in October.